Other Stories

U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients Updated: 2020-08-24 10:01:27 KST

Let's begin with a potentially important update about treating COVID-19 patients.
The U.S. Food and Drug Administration has approved emergency authorization of convalescent plasma to treat the virus.
More than 70-thousand Americans have already received the treatment from medical clinics, but now it has been given the green light by the FDA.
Speaking at the White House Sunday, President Trump said the treatment could save countless lives.

"The FDA has issued an emergency use authorization, and that's such a powerful term emergency use authorization for a treatment known as convalescent plasma."

Trump added that the authorized therapy transfuses strong antibodies from the blood of COVID-19 survivors into those critically ill due to the virus.
The theory is that the antibodies should help sufferers fight COVID-19.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.